Klijn JG - Search Results

1

Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.

Helle SI, Mietlowski W, Guastalla JP, Szakolczai I, Bajetta E, Sommer H, Baltali E, Pinter T, Csepreghy M, Ottestad L, Boni C, Bryce C, Klijn JG, Lønning PE. Helle SI, et al. Among authors: klijn jg. Eur J Cancer. 2005 Mar;41(5):694-701. doi: 10.1016/j.ejca.2004.12.015. Epub 2005 Jan 21. Eur J Cancer. 2005. PMID: 15763644 Clinical Trial.

2

Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research.

Rubens RD, Bajetta E, Bonneterre J, Klijn JG, Lønning PE, Paridaens R. Rubens RD, et al. Among authors: klijn jg. Eur J Cancer. 1994;30A(1):106-11. doi: 10.1016/s0959-8049(05)80029-2. Eur J Cancer. 1994. PMID: 8142150 Review. No abstract available.

3

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Bontenbal M, Foekens JA, Lamberts SW, de Jong FH, van Putten WL, Braun HJ, Burghouts JT, van der Linden GH, Klijn JG. Bontenbal M, et al. Among authors: klijn jg. Br J Cancer. 1998;77(1):115-22. doi: 10.1038/bjc.1998.18. Br J Cancer. 1998. PMID: 9459155 Free PMC article. Clinical Trial.

4

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.

Meijer-van Gelder ME, Look MP, Peters HA, Schmitt M, Brünner N, Harbeck N, Klijn JG, Foekens JA. Meijer-van Gelder ME, et al. Among authors: klijn jg. Cancer Res. 2004 Jul 1;64(13):4563-8. doi: 10.1158/0008-5472.CAN-03-3848. Cancer Res. 2004. PMID: 15231667

5

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M, Klijn JG. Foekens JA, et al. Among authors: klijn jg. Br J Cancer. 1994 Dec;70(6):1217-23. doi: 10.1038/bjc.1994.476. Br J Cancer. 1994. PMID: 7981080 Free PMC article.

6

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG. Foekens JA, et al. Among authors: klijn jg. Cancer Res. 2001 Jul 15;61(14):5407-14. Cancer Res. 2001. PMID: 11454684

7

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.

Foekens JA, Ries Ch, Look MP, Gippner-Steppert C, Klijn JG, Jochum M. Foekens JA, et al. Among authors: klijn jg. Br J Cancer. 2003 Apr 7;88(7):1084-90. doi: 10.1038/sj.bjc.6600813. Br J Cancer. 2003. PMID: 12671709 Free PMC article.

8

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.

Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, vd Ouweland A, Menke-Pluymers MB, Bartels CC, Kriege M, van Geel AN, Burger CW, Eggermont AM, Meijers-Heijboer H, Klijn JG. Brekelmans CT, et al. Among authors: klijn jg. Eur J Cancer. 2007 Mar;43(5):867-76. doi: 10.1016/j.ejca.2006.12.009. Epub 2007 Feb 20. Eur J Cancer. 2007. PMID: 17307353

9

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

Seynaeve C, Verhoog LC, van de Bosch LM, van Geel AN, Menke-Pluymers M, Meijers-Heijboer EJ, van den Ouweland AM, Wagner A, Creutzberg CL, Niermeijer MF, Klijn JG, Brekelmans CT. Seynaeve C, et al. Among authors: klijn jg. Eur J Cancer. 2004 May;40(8):1150-8. doi: 10.1016/j.ejca.2004.01.017. Eur J Cancer. 2004. PMID: 15110878

10

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.

Jansen MP, Foekens JA, van Staveren IL, Dirkzwager-Kiel MM, Ritstier K, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Portengen H, Dorssers LC, Klijn JG, Berns EM. Jansen MP, et al. Among authors: klijn jg. J Clin Oncol. 2005 Feb 1;23(4):732-40. doi: 10.1200/JCO.2005.05.145. J Clin Oncol. 2005. PMID: 15681518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page